RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis Meeting Abstract


Authors: Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Alekseev, B.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Collins, L. T.; Brechenmacher, T.; Lin, C.; Morgan, L.; Motzer, R.
Abstract Title: RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis
Meeting Title: 15th International Kidney Cancer Symposium
Journal Title: BJU International
Volume: 118
Issue: Suppl. 5
Meeting Dates: 2016 Nov 4-5
Meeting Location: Miami, FL
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2016-12-01
Start Page: 18
End Page: 19
Language: English
ACCESSION: WOS:000388478200029
PROVIDER: wos
PUBMED: 27860174
DOI: 10.1111/bju.13694
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer